Table 4.
Distribution of Genotype and Allelic frequencies of the ADBR2 gene between Leiomyoma and Control Population and risk analysis
|
Genotype
frequency |
Leiomyomas
N (%) |
Controls
N (%) |
p* |
OR
IC (95%) |
|---|---|---|---|---|
| AA | 39 (42.9) | 37 (24.5) | ||
| AG | 48 (52.7) | 75 (49.7) | <0.001 | - |
| GG | 4 (4.4) | 39 (25.8) | ||
| AA | 39 (42.9) | 37 (24.5) | 2.311 | |
| AG+GG | 52 (57.1) | 114 (75.5) | 0.003 | (1.324-4.032) |
| AA+AG GG |
87 (95.6) 4 (4.4) |
112 (74.2) 39 (25.8) |
<0.001 | 7.574 (2.607-22.002) |
| Allele frequencies | Leiomyomas N (%) | Controls N (%) | p* | OR IC (95%) |
| A | 126 (69.2) | 149 (49.3) | 2.310 | |
| G | 56 (30.8) | 153 (50.7) | <0.001 | (1.569-3.403) |
*χ2 – test